CHUNGBUK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION;오토텔릭바이오 주식회사;충북대학교 산학협력단;AUTOTELIC BIO INC.;오토텔릭바이오 주식회사;충북대학교 산학협력단
发明人:
KIM TAE HUN,김태훈,PARK JUN EUI,박전의,PARK CHUN WOONG,박천웅,OH DONG WON,오동원,CHOI JAE CHEOL,최재철
申请号：
KR1020180130689
公开号：
KR1020200048516A
申请日:
2018.10.30
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
Disclosed is a pharmaceutical composition which contains: celecoxib or a pharmaceutically acceptable salt thereof； olmesartan medoxomil； and a disintegrating agent, as active components. According to the present invention, it is possible to improve the bioavailability and therapeutic effects by improving the dissolution rate of a medicine for treating osteoarthritis and a medicine for treating hypertension.COPYRIGHT KIPO 2020유효성분으로서 세레콕시브 또는 이의 약제학적으로 허용되는 염； 올메사르탄 메독소밀； 및 붕해제를 포함하는 의약 조성물이 제공된다.
